nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—SLCO1B1—Penicillamine—rheumatoid arthritis	0.287	0.473	CbGbCtD
Valsartan—ALB—rheumatoid arthritis	0.224	1	CbGaD
Valsartan—ALB—Auranofin—rheumatoid arthritis	0.0768	0.127	CbGbCtD
Valsartan—SLCO1B1—Sulfasalazine—rheumatoid arthritis	0.0558	0.092	CbGbCtD
Valsartan—SLCO1B1—Cyclosporine—rheumatoid arthritis	0.0423	0.0697	CbGbCtD
Valsartan—SLCO1B3—Methotrexate—rheumatoid arthritis	0.0384	0.0634	CbGbCtD
Valsartan—CYP2C9—Leflunomide—rheumatoid arthritis	0.0267	0.044	CbGbCtD
Valsartan—ALB—Prednisone—rheumatoid arthritis	0.0244	0.0403	CbGbCtD
Valsartan—SLCO1B1—Methotrexate—rheumatoid arthritis	0.0224	0.0369	CbGbCtD
Valsartan—CYP2C9—Cyclosporine—rheumatoid arthritis	0.0125	0.0206	CbGbCtD
Valsartan—ALB—Methotrexate—rheumatoid arthritis	0.0123	0.0202	CbGbCtD
Valsartan—CYP2C9—Dexamethasone—rheumatoid arthritis	0.00822	0.0136	CbGbCtD
Valsartan—Angiopathy—Prednisone—rheumatoid arthritis	0.000136	0.00111	CcSEcCtD
Valsartan—Immune system disorder—Prednisone—rheumatoid arthritis	0.000136	0.0011	CcSEcCtD
Valsartan—Oedema—Triamcinolone—rheumatoid arthritis	0.000135	0.0011	CcSEcCtD
Valsartan—Anaphylactic shock—Triamcinolone—rheumatoid arthritis	0.000135	0.0011	CcSEcCtD
Valsartan—Vertigo—Dexamethasone—rheumatoid arthritis	0.000135	0.0011	CcSEcCtD
Valsartan—Vertigo—Betamethasone—rheumatoid arthritis	0.000135	0.0011	CcSEcCtD
Valsartan—Anaphylactic shock—Methylprednisolone—rheumatoid arthritis	0.000135	0.0011	CcSEcCtD
Valsartan—Syncope—Dexamethasone—rheumatoid arthritis	0.000134	0.00109	CcSEcCtD
Valsartan—Syncope—Betamethasone—rheumatoid arthritis	0.000134	0.00109	CcSEcCtD
Valsartan—Infection—Triamcinolone—rheumatoid arthritis	0.000134	0.00109	CcSEcCtD
Valsartan—Hypotension—Hydrocortisone—rheumatoid arthritis	0.000134	0.00109	CcSEcCtD
Valsartan—Infection—Methylprednisolone—rheumatoid arthritis	0.000134	0.00109	CcSEcCtD
Valsartan—Vomiting—Leflunomide—rheumatoid arthritis	0.000133	0.00108	CcSEcCtD
Valsartan—Shock—Triamcinolone—rheumatoid arthritis	0.000133	0.00108	CcSEcCtD
Valsartan—Insomnia—Prednisolone—rheumatoid arthritis	0.000133	0.00108	CcSEcCtD
Valsartan—Alopecia—Prednisone—rheumatoid arthritis	0.000133	0.00108	CcSEcCtD
Valsartan—Shock—Methylprednisolone—rheumatoid arthritis	0.000132	0.00108	CcSEcCtD
Valsartan—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000132	0.00107	CcSEcCtD
Valsartan—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000132	0.00107	CcSEcCtD
Valsartan—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.000132	0.00107	CcSEcCtD
Valsartan—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.000132	0.00107	CcSEcCtD
Valsartan—Epistaxis—Methotrexate—rheumatoid arthritis	0.000132	0.00107	CcSEcCtD
Valsartan—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000132	0.00107	CcSEcCtD
Valsartan—Rash—Leflunomide—rheumatoid arthritis	0.000132	0.00107	CcSEcCtD
Valsartan—Dermatitis—Leflunomide—rheumatoid arthritis	0.000132	0.00107	CcSEcCtD
Valsartan—Mental disorder—Prednisone—rheumatoid arthritis	0.000131	0.00107	CcSEcCtD
Valsartan—Nausea—Azathioprine—rheumatoid arthritis	0.000131	0.00107	CcSEcCtD
Valsartan—Headache—Leflunomide—rheumatoid arthritis	0.000131	0.00106	CcSEcCtD
Valsartan—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000131	0.00106	CcSEcCtD
Valsartan—Malnutrition—Prednisone—rheumatoid arthritis	0.000131	0.00106	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000131	0.00106	CcSEcCtD
Valsartan—Insomnia—Hydrocortisone—rheumatoid arthritis	0.00013	0.00105	CcSEcCtD
Valsartan—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000129	0.00105	CcSEcCtD
Valsartan—Urticaria—Cyclosporine—rheumatoid arthritis	0.000128	0.00104	CcSEcCtD
Valsartan—Myalgia—Dexamethasone—rheumatoid arthritis	0.000128	0.00104	CcSEcCtD
Valsartan—Myalgia—Betamethasone—rheumatoid arthritis	0.000128	0.00104	CcSEcCtD
Valsartan—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000127	0.00104	CcSEcCtD
Valsartan—Anxiety—Dexamethasone—rheumatoid arthritis	0.000127	0.00104	CcSEcCtD
Valsartan—Anxiety—Betamethasone—rheumatoid arthritis	0.000127	0.00104	CcSEcCtD
Valsartan—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000126	0.00103	CcSEcCtD
Valsartan—Haemoglobin—Methotrexate—rheumatoid arthritis	0.000126	0.00103	CcSEcCtD
Valsartan—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000126	0.00102	CcSEcCtD
Valsartan—Haemorrhage—Methotrexate—rheumatoid arthritis	0.000125	0.00102	CcSEcCtD
Valsartan—Hepatitis—Methotrexate—rheumatoid arthritis	0.000125	0.00102	CcSEcCtD
Valsartan—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000125	0.00101	CcSEcCtD
Valsartan—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000124	0.00101	CcSEcCtD
Valsartan—Nausea—Leflunomide—rheumatoid arthritis	0.000124	0.00101	CcSEcCtD
Valsartan—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000124	0.00101	CcSEcCtD
Valsartan—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000124	0.00101	CcSEcCtD
Valsartan—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000124	0.00101	CcSEcCtD
Valsartan—Vision blurred—Prednisone—rheumatoid arthritis	0.000123	0.001	CcSEcCtD
Valsartan—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000123	0.001	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000123	0.001	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000123	0.000998	CcSEcCtD
Valsartan—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000122	0.000996	CcSEcCtD
Valsartan—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000122	0.000996	CcSEcCtD
Valsartan—Oedema—Dexamethasone—rheumatoid arthritis	0.000122	0.000996	CcSEcCtD
Valsartan—Oedema—Betamethasone—rheumatoid arthritis	0.000122	0.000996	CcSEcCtD
Valsartan—Insomnia—Triamcinolone—rheumatoid arthritis	0.000122	0.000993	CcSEcCtD
Valsartan—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000122	0.000991	CcSEcCtD
Valsartan—Infection—Betamethasone—rheumatoid arthritis	0.000122	0.00099	CcSEcCtD
Valsartan—Infection—Dexamethasone—rheumatoid arthritis	0.000122	0.00099	CcSEcCtD
Valsartan—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000121	0.000986	CcSEcCtD
Valsartan—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000121	0.000984	CcSEcCtD
Valsartan—Shock—Betamethasone—rheumatoid arthritis	0.00012	0.00098	CcSEcCtD
Valsartan—Shock—Dexamethasone—rheumatoid arthritis	0.00012	0.00098	CcSEcCtD
Valsartan—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.00012	0.000979	CcSEcCtD
Valsartan—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.00012	0.000977	CcSEcCtD
Valsartan—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.00012	0.000977	CcSEcCtD
Valsartan—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.00012	0.000975	CcSEcCtD
Valsartan—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.00012	0.000975	CcSEcCtD
Valsartan—Angioedema—Prednisone—rheumatoid arthritis	0.000119	0.000971	CcSEcCtD
Valsartan—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000119	0.000967	CcSEcCtD
Valsartan—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000119	0.000966	CcSEcCtD
Valsartan—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000118	0.000964	CcSEcCtD
Valsartan—Vertigo—Prednisone—rheumatoid arthritis	0.000117	0.000955	CcSEcCtD
Valsartan—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000117	0.000953	CcSEcCtD
Valsartan—Syncope—Prednisone—rheumatoid arthritis	0.000117	0.000953	CcSEcCtD
Valsartan—Anorexia—Dexamethasone—rheumatoid arthritis	0.000117	0.00095	CcSEcCtD
Valsartan—Anorexia—Betamethasone—rheumatoid arthritis	0.000117	0.00095	CcSEcCtD
Valsartan—Urticaria—Prednisolone—rheumatoid arthritis	0.000117	0.000948	CcSEcCtD
Valsartan—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000116	0.000947	CcSEcCtD
Valsartan—Fatigue—Triamcinolone—rheumatoid arthritis	0.000116	0.000947	CcSEcCtD
Valsartan—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000116	0.000944	CcSEcCtD
Valsartan—Asthenia—Cyclosporine—rheumatoid arthritis	0.000116	0.000941	CcSEcCtD
Valsartan—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000115	0.000934	CcSEcCtD
Valsartan—Hypotension—Dexamethasone—rheumatoid arthritis	0.000114	0.000931	CcSEcCtD
Valsartan—Hypotension—Betamethasone—rheumatoid arthritis	0.000114	0.000931	CcSEcCtD
Valsartan—Pruritus—Cyclosporine—rheumatoid arthritis	0.000114	0.000928	CcSEcCtD
Valsartan—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000114	0.000926	CcSEcCtD
Valsartan—Angiopathy—Methotrexate—rheumatoid arthritis	0.000114	0.000926	CcSEcCtD
Valsartan—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000113	0.000922	CcSEcCtD
Valsartan—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000113	0.000922	CcSEcCtD
Valsartan—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000113	0.00092	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000112	0.000908	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000112	0.000908	CcSEcCtD
Valsartan—Myalgia—Prednisone—rheumatoid arthritis	0.000111	0.000905	CcSEcCtD
Valsartan—Arthralgia—Prednisone—rheumatoid arthritis	0.000111	0.000905	CcSEcCtD
Valsartan—Anxiety—Prednisone—rheumatoid arthritis	0.000111	0.000902	CcSEcCtD
Valsartan—Alopecia—Methotrexate—rheumatoid arthritis	0.000111	0.000902	CcSEcCtD
Valsartan—Insomnia—Dexamethasone—rheumatoid arthritis	0.000111	0.000901	CcSEcCtD
Valsartan—Insomnia—Betamethasone—rheumatoid arthritis	0.000111	0.000901	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.00011	0.000899	CcSEcCtD
Valsartan—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.00011	0.000898	CcSEcCtD
Valsartan—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.00011	0.000896	CcSEcCtD
Valsartan—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.00011	0.000894	CcSEcCtD
Valsartan—Paraesthesia—Betamethasone—rheumatoid arthritis	0.00011	0.000894	CcSEcCtD
Valsartan—Mental disorder—Methotrexate—rheumatoid arthritis	0.00011	0.000894	CcSEcCtD
Valsartan—Malnutrition—Methotrexate—rheumatoid arthritis	0.000109	0.000888	CcSEcCtD
Valsartan—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000108	0.00088	CcSEcCtD
Valsartan—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000108	0.000877	CcSEcCtD
Valsartan—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000108	0.000877	CcSEcCtD
Valsartan—Urticaria—Triamcinolone—rheumatoid arthritis	0.000107	0.000872	CcSEcCtD
Valsartan—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000107	0.00087	CcSEcCtD
Valsartan—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000107	0.00087	CcSEcCtD
Valsartan—Dizziness—Cyclosporine—rheumatoid arthritis	0.000107	0.000868	CcSEcCtD
Valsartan—Oedema—Prednisone—rheumatoid arthritis	0.000107	0.000868	CcSEcCtD
Valsartan—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000107	0.000868	CcSEcCtD
Valsartan—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000106	0.000866	CcSEcCtD
Valsartan—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000106	0.000866	CcSEcCtD
Valsartan—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000106	0.000866	CcSEcCtD
Valsartan—Infection—Prednisone—rheumatoid arthritis	0.000106	0.000862	CcSEcCtD
Valsartan—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000106	0.00086	CcSEcCtD
Valsartan—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000106	0.00086	CcSEcCtD
Valsartan—Back pain—Methotrexate—rheumatoid arthritis	0.000106	0.000859	CcSEcCtD
Valsartan—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000106	0.000859	CcSEcCtD
Valsartan—Fatigue—Betamethasone—rheumatoid arthritis	0.000106	0.000859	CcSEcCtD
Valsartan—Fatigue—Dexamethasone—rheumatoid arthritis	0.000106	0.000859	CcSEcCtD
Valsartan—Shock—Prednisone—rheumatoid arthritis	0.000105	0.000854	CcSEcCtD
Valsartan—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000105	0.000851	CcSEcCtD
Valsartan—Skin disorder—Prednisone—rheumatoid arthritis	0.000104	0.000843	CcSEcCtD
Valsartan—Vision blurred—Methotrexate—rheumatoid arthritis	0.000103	0.000837	CcSEcCtD
Valsartan—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000103	0.000837	CcSEcCtD
Valsartan—Vomiting—Cyclosporine—rheumatoid arthritis	0.000102	0.000834	CcSEcCtD
Valsartan—Rash—Cyclosporine—rheumatoid arthritis	0.000102	0.000827	CcSEcCtD
Valsartan—Anorexia—Prednisone—rheumatoid arthritis	0.000102	0.000827	CcSEcCtD
Valsartan—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000102	0.000826	CcSEcCtD
Valsartan—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000101	0.000825	CcSEcCtD
Valsartan—Headache—Cyclosporine—rheumatoid arthritis	0.000101	0.000822	CcSEcCtD
Valsartan—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.0001	0.000815	CcSEcCtD
Valsartan—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.0001	0.000815	CcSEcCtD
Valsartan—Hypersensitivity—Triamcinolone—rheumatoid arthritis	9.94e-05	0.000809	CcSEcCtD
Valsartan—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	9.92e-05	0.000807	CcSEcCtD
Valsartan—Vertigo—Methotrexate—rheumatoid arthritis	9.81e-05	0.000798	CcSEcCtD
Valsartan—Diarrhoea—Hydrocortisone—rheumatoid arthritis	9.8e-05	0.000798	CcSEcCtD
Valsartan—Urticaria—Dexamethasone—rheumatoid arthritis	9.72e-05	0.000791	CcSEcCtD
Valsartan—Urticaria—Betamethasone—rheumatoid arthritis	9.72e-05	0.000791	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	9.71e-05	0.00079	CcSEcCtD
Valsartan—Dizziness—Prednisolone—rheumatoid arthritis	9.7e-05	0.000789	CcSEcCtD
Valsartan—Asthenia—Triamcinolone—rheumatoid arthritis	9.68e-05	0.000788	CcSEcCtD
Valsartan—Abdominal pain—Dexamethasone—rheumatoid arthritis	9.67e-05	0.000787	CcSEcCtD
Valsartan—Abdominal pain—Betamethasone—rheumatoid arthritis	9.67e-05	0.000787	CcSEcCtD
Valsartan—Asthenia—Methylprednisolone—rheumatoid arthritis	9.66e-05	0.000786	CcSEcCtD
Valsartan—Insomnia—Prednisone—rheumatoid arthritis	9.64e-05	0.000785	CcSEcCtD
Valsartan—Nausea—Cyclosporine—rheumatoid arthritis	9.57e-05	0.000779	CcSEcCtD
Valsartan—Paraesthesia—Prednisone—rheumatoid arthritis	9.57e-05	0.000779	CcSEcCtD
Valsartan—Pruritus—Triamcinolone—rheumatoid arthritis	9.54e-05	0.000777	CcSEcCtD
Valsartan—Cough—Methotrexate—rheumatoid arthritis	9.52e-05	0.000775	CcSEcCtD
Valsartan—Pruritus—Methylprednisolone—rheumatoid arthritis	9.52e-05	0.000775	CcSEcCtD
Valsartan—Dizziness—Hydrocortisone—rheumatoid arthritis	9.47e-05	0.000771	CcSEcCtD
Valsartan—Dyspepsia—Prednisone—rheumatoid arthritis	9.38e-05	0.000764	CcSEcCtD
Valsartan—Chest pain—Methotrexate—rheumatoid arthritis	9.29e-05	0.000756	CcSEcCtD
Valsartan—Arthralgia—Methotrexate—rheumatoid arthritis	9.29e-05	0.000756	CcSEcCtD
Valsartan—Myalgia—Methotrexate—rheumatoid arthritis	9.29e-05	0.000756	CcSEcCtD
Valsartan—Decreased appetite—Prednisone—rheumatoid arthritis	9.27e-05	0.000754	CcSEcCtD
Valsartan—Rash—Prednisolone—rheumatoid arthritis	9.25e-05	0.000753	CcSEcCtD
Valsartan—Dermatitis—Prednisolone—rheumatoid arthritis	9.24e-05	0.000752	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	9.23e-05	0.000751	CcSEcCtD
Valsartan—Diarrhoea—Methylprednisolone—rheumatoid arthritis	9.21e-05	0.00075	CcSEcCtD
Valsartan—Fatigue—Prednisone—rheumatoid arthritis	9.19e-05	0.000748	CcSEcCtD
Valsartan—Headache—Prednisolone—rheumatoid arthritis	9.19e-05	0.000748	CcSEcCtD
Valsartan—Constipation—Prednisone—rheumatoid arthritis	9.11e-05	0.000742	CcSEcCtD
Valsartan—Vomiting—Hydrocortisone—rheumatoid arthritis	9.11e-05	0.000741	CcSEcCtD
Valsartan—Rash—Hydrocortisone—rheumatoid arthritis	9.03e-05	0.000735	CcSEcCtD
Valsartan—Dermatitis—Hydrocortisone—rheumatoid arthritis	9.02e-05	0.000734	CcSEcCtD
Valsartan—Headache—Hydrocortisone—rheumatoid arthritis	8.97e-05	0.00073	CcSEcCtD
Valsartan—Dizziness—Triamcinolone—rheumatoid arthritis	8.92e-05	0.000726	CcSEcCtD
Valsartan—Anaphylactic shock—Methotrexate—rheumatoid arthritis	8.91e-05	0.000725	CcSEcCtD
Valsartan—Dizziness—Methylprednisolone—rheumatoid arthritis	8.9e-05	0.000724	CcSEcCtD
Valsartan—Infection—Methotrexate—rheumatoid arthritis	8.85e-05	0.00072	CcSEcCtD
Valsartan—Asthenia—Dexamethasone—rheumatoid arthritis	8.78e-05	0.000715	CcSEcCtD
Valsartan—Asthenia—Betamethasone—rheumatoid arthritis	8.78e-05	0.000715	CcSEcCtD
Valsartan—Nervous system disorder—Methotrexate—rheumatoid arthritis	8.74e-05	0.000711	CcSEcCtD
Valsartan—Thrombocytopenia—Methotrexate—rheumatoid arthritis	8.72e-05	0.00071	CcSEcCtD
Valsartan—Gastrointestinal pain—Prednisone—rheumatoid arthritis	8.72e-05	0.000709	CcSEcCtD
Valsartan—Nausea—Prednisolone—rheumatoid arthritis	8.71e-05	0.000709	CcSEcCtD
Valsartan—Pruritus—Betamethasone—rheumatoid arthritis	8.66e-05	0.000705	CcSEcCtD
Valsartan—Pruritus—Dexamethasone—rheumatoid arthritis	8.66e-05	0.000705	CcSEcCtD
Valsartan—Skin disorder—Methotrexate—rheumatoid arthritis	8.65e-05	0.000704	CcSEcCtD
Valsartan—Vomiting—Triamcinolone—rheumatoid arthritis	8.58e-05	0.000698	CcSEcCtD
Valsartan—Vomiting—Methylprednisolone—rheumatoid arthritis	8.56e-05	0.000696	CcSEcCtD
Valsartan—Nausea—Hydrocortisone—rheumatoid arthritis	8.51e-05	0.000693	CcSEcCtD
Valsartan—Rash—Triamcinolone—rheumatoid arthritis	8.5e-05	0.000692	CcSEcCtD
Valsartan—Dermatitis—Triamcinolone—rheumatoid arthritis	8.5e-05	0.000692	CcSEcCtD
Valsartan—Anorexia—Methotrexate—rheumatoid arthritis	8.49e-05	0.000691	CcSEcCtD
Valsartan—Rash—Methylprednisolone—rheumatoid arthritis	8.49e-05	0.000691	CcSEcCtD
Valsartan—Dermatitis—Methylprednisolone—rheumatoid arthritis	8.48e-05	0.00069	CcSEcCtD
Valsartan—Urticaria—Prednisone—rheumatoid arthritis	8.47e-05	0.000689	CcSEcCtD
Valsartan—Headache—Triamcinolone—rheumatoid arthritis	8.45e-05	0.000688	CcSEcCtD
Valsartan—Headache—Methylprednisolone—rheumatoid arthritis	8.43e-05	0.000686	CcSEcCtD
Valsartan—Abdominal pain—Prednisone—rheumatoid arthritis	8.43e-05	0.000686	CcSEcCtD
Valsartan—Diarrhoea—Betamethasone—rheumatoid arthritis	8.37e-05	0.000682	CcSEcCtD
Valsartan—Diarrhoea—Dexamethasone—rheumatoid arthritis	8.37e-05	0.000682	CcSEcCtD
Valsartan—Hypotension—Methotrexate—rheumatoid arthritis	8.32e-05	0.000677	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	8.12e-05	0.000661	CcSEcCtD
Valsartan—Dizziness—Dexamethasone—rheumatoid arthritis	8.09e-05	0.000659	CcSEcCtD
Valsartan—Dizziness—Betamethasone—rheumatoid arthritis	8.09e-05	0.000659	CcSEcCtD
Valsartan—Insomnia—Methotrexate—rheumatoid arthritis	8.06e-05	0.000656	CcSEcCtD
Valsartan—Nausea—Triamcinolone—rheumatoid arthritis	8.01e-05	0.000652	CcSEcCtD
Valsartan—Paraesthesia—Methotrexate—rheumatoid arthritis	8e-05	0.000651	CcSEcCtD
Valsartan—Nausea—Methylprednisolone—rheumatoid arthritis	7.99e-05	0.000651	CcSEcCtD
Valsartan—Dyspnoea—Methotrexate—rheumatoid arthritis	7.94e-05	0.000646	CcSEcCtD
Valsartan—Somnolence—Methotrexate—rheumatoid arthritis	7.92e-05	0.000645	CcSEcCtD
Valsartan—Hypersensitivity—Prednisone—rheumatoid arthritis	7.85e-05	0.000639	CcSEcCtD
Valsartan—Dyspepsia—Methotrexate—rheumatoid arthritis	7.84e-05	0.000638	CcSEcCtD
Valsartan—Vomiting—Betamethasone—rheumatoid arthritis	7.78e-05	0.000633	CcSEcCtD
Valsartan—Vomiting—Dexamethasone—rheumatoid arthritis	7.78e-05	0.000633	CcSEcCtD
Valsartan—Decreased appetite—Methotrexate—rheumatoid arthritis	7.74e-05	0.00063	CcSEcCtD
Valsartan—Rash—Dexamethasone—rheumatoid arthritis	7.72e-05	0.000628	CcSEcCtD
Valsartan—Rash—Betamethasone—rheumatoid arthritis	7.72e-05	0.000628	CcSEcCtD
Valsartan—Dermatitis—Dexamethasone—rheumatoid arthritis	7.71e-05	0.000628	CcSEcCtD
Valsartan—Dermatitis—Betamethasone—rheumatoid arthritis	7.71e-05	0.000628	CcSEcCtD
Valsartan—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	7.69e-05	0.000626	CcSEcCtD
Valsartan—Fatigue—Methotrexate—rheumatoid arthritis	7.68e-05	0.000625	CcSEcCtD
Valsartan—Headache—Dexamethasone—rheumatoid arthritis	7.67e-05	0.000624	CcSEcCtD
Valsartan—Headache—Betamethasone—rheumatoid arthritis	7.67e-05	0.000624	CcSEcCtD
Valsartan—Asthenia—Prednisone—rheumatoid arthritis	7.65e-05	0.000622	CcSEcCtD
Valsartan—Pruritus—Prednisone—rheumatoid arthritis	7.54e-05	0.000614	CcSEcCtD
Valsartan—Diarrhoea—Prednisone—rheumatoid arthritis	7.29e-05	0.000594	CcSEcCtD
Valsartan—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	7.28e-05	0.000593	CcSEcCtD
Valsartan—Nausea—Betamethasone—rheumatoid arthritis	7.27e-05	0.000592	CcSEcCtD
Valsartan—Nausea—Dexamethasone—rheumatoid arthritis	7.27e-05	0.000592	CcSEcCtD
Valsartan—Urticaria—Methotrexate—rheumatoid arthritis	7.08e-05	0.000576	CcSEcCtD
Valsartan—Dizziness—Prednisone—rheumatoid arthritis	7.05e-05	0.000574	CcSEcCtD
Valsartan—Abdominal pain—Methotrexate—rheumatoid arthritis	7.04e-05	0.000573	CcSEcCtD
Valsartan—Vomiting—Prednisone—rheumatoid arthritis	6.78e-05	0.000552	CcSEcCtD
Valsartan—Rash—Prednisone—rheumatoid arthritis	6.72e-05	0.000547	CcSEcCtD
Valsartan—Dermatitis—Prednisone—rheumatoid arthritis	6.71e-05	0.000546	CcSEcCtD
Valsartan—Headache—Prednisone—rheumatoid arthritis	6.68e-05	0.000543	CcSEcCtD
Valsartan—Hypersensitivity—Methotrexate—rheumatoid arthritis	6.56e-05	0.000534	CcSEcCtD
Valsartan—Asthenia—Methotrexate—rheumatoid arthritis	6.39e-05	0.00052	CcSEcCtD
Valsartan—Nausea—Prednisone—rheumatoid arthritis	6.33e-05	0.000515	CcSEcCtD
Valsartan—Pruritus—Methotrexate—rheumatoid arthritis	6.3e-05	0.000513	CcSEcCtD
Valsartan—Diarrhoea—Methotrexate—rheumatoid arthritis	6.09e-05	0.000496	CcSEcCtD
Valsartan—Dizziness—Methotrexate—rheumatoid arthritis	5.89e-05	0.000479	CcSEcCtD
Valsartan—Vomiting—Methotrexate—rheumatoid arthritis	5.66e-05	0.000461	CcSEcCtD
Valsartan—Rash—Methotrexate—rheumatoid arthritis	5.62e-05	0.000457	CcSEcCtD
Valsartan—Dermatitis—Methotrexate—rheumatoid arthritis	5.61e-05	0.000457	CcSEcCtD
Valsartan—Headache—Methotrexate—rheumatoid arthritis	5.58e-05	0.000454	CcSEcCtD
Valsartan—Nausea—Methotrexate—rheumatoid arthritis	5.29e-05	0.000431	CcSEcCtD
Valsartan—AGTR1—GPCR downstream signaling—SAA1—rheumatoid arthritis	5.21e-05	0.00112	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—rheumatoid arthritis	5.2e-05	0.00112	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PDE2A—rheumatoid arthritis	5.16e-05	0.00111	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PLB1—rheumatoid arthritis	5.13e-05	0.0011	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—CCL2—rheumatoid arthritis	5.1e-05	0.00109	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PDE2A—rheumatoid arthritis	5.09e-05	0.00109	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	4.93e-05	0.00106	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PLB1—rheumatoid arthritis	4.92e-05	0.00105	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL1B—rheumatoid arthritis	4.87e-05	0.00104	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL2—rheumatoid arthritis	4.85e-05	0.00104	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CXCL2—rheumatoid arthritis	4.84e-05	0.00104	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CCL3—rheumatoid arthritis	4.84e-05	0.00104	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—TIMP1—rheumatoid arthritis	4.83e-05	0.00103	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	4.76e-05	0.00102	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	4.76e-05	0.00102	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—SAA1—rheumatoid arthritis	4.73e-05	0.00101	CbGpPWpGaD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	4.7e-05	0.00101	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PLEK—rheumatoid arthritis	4.66e-05	0.000999	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—NFKB1—rheumatoid arthritis	4.54e-05	0.000974	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—RBPJ—rheumatoid arthritis	4.54e-05	0.000973	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	4.53e-05	0.000971	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CXCL12—rheumatoid arthritis	4.53e-05	0.000971	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	4.53e-05	0.00097	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MED1—rheumatoid arthritis	4.5e-05	0.000965	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	4.48e-05	0.00096	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	4.42e-05	0.000949	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	4.41e-05	0.000946	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	4.36e-05	0.000935	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—RASGRP1—rheumatoid arthritis	4.34e-05	0.000931	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—TNF—rheumatoid arthritis	4.34e-05	0.000931	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IFNG—rheumatoid arthritis	4.34e-05	0.000929	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—SYK—rheumatoid arthritis	4.33e-05	0.000928	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—POMC—rheumatoid arthritis	4.29e-05	0.00092	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—PRKCQ—rheumatoid arthritis	4.25e-05	0.000911	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	4.22e-05	0.000906	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CCL2—rheumatoid arthritis	4.2e-05	0.000901	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PLD4—rheumatoid arthritis	4.2e-05	0.0009	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ACP5—rheumatoid arthritis	4.18e-05	0.000897	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—B3GNT2—rheumatoid arthritis	4.18e-05	0.000897	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—PTGS2—rheumatoid arthritis	4.16e-05	0.000891	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	4.13e-05	0.000886	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CXCL12—rheumatoid arthritis	4.11e-05	0.000882	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—BDKRB2—rheumatoid arthritis	4.11e-05	0.000882	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—ADRBK1—rheumatoid arthritis	4.07e-05	0.000872	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ACAN—rheumatoid arthritis	4.06e-05	0.00087	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCL13—rheumatoid arthritis	4.01e-05	0.00086	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CXCL10—rheumatoid arthritis	4e-05	0.000858	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	3.9e-05	0.000835	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	3.9e-05	0.000835	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	3.88e-05	0.000832	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	3.87e-05	0.000829	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—RASGRP1—rheumatoid arthritis	3.84e-05	0.000822	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—SLC25A12—rheumatoid arthritis	3.81e-05	0.000818	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—BGN—rheumatoid arthritis	3.77e-05	0.000808	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—PRKCQ—rheumatoid arthritis	3.75e-05	0.000805	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GC—rheumatoid arthritis	3.71e-05	0.000795	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTGES—rheumatoid arthritis	3.71e-05	0.000795	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	3.69e-05	0.000791	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CXCL10—rheumatoid arthritis	3.63e-05	0.000779	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	3.62e-05	0.000777	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—PTK2—rheumatoid arthritis	3.61e-05	0.000775	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TLE3—rheumatoid arthritis	3.61e-05	0.000774	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IRAK1—rheumatoid arthritis	3.61e-05	0.000774	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	3.61e-05	0.000773	CbGpPWpGaD
Valsartan—ALB—Metabolism—FADS2—rheumatoid arthritis	3.6e-05	0.000771	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CX3CR1—rheumatoid arthritis	3.57e-05	0.000766	CbGpPWpGaD
Valsartan—ALB—Platelet degranulation—VEGFA—rheumatoid arthritis	3.53e-05	0.000758	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—TNF—rheumatoid arthritis	3.53e-05	0.000757	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—IL6—rheumatoid arthritis	3.5e-05	0.000751	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—rheumatoid arthritis	3.5e-05	0.000749	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—CSF2—rheumatoid arthritis	3.49e-05	0.000748	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ALOX5—rheumatoid arthritis	3.47e-05	0.000743	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PLB1—rheumatoid arthritis	3.45e-05	0.000739	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CCL5—rheumatoid arthritis	3.45e-05	0.000739	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL2RB—rheumatoid arthritis	3.44e-05	0.000738	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IL2RB—rheumatoid arthritis	3.4e-05	0.000729	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CSF2—rheumatoid arthritis	3.39e-05	0.000728	CbGpPWpGaD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—rheumatoid arthritis	3.37e-05	0.000722	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—C5—rheumatoid arthritis	3.32e-05	0.000712	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CXCL8—rheumatoid arthritis	3.32e-05	0.000712	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—MMP3—rheumatoid arthritis	3.32e-05	0.000711	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	3.31e-05	0.000709	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SELE—rheumatoid arthritis	3.28e-05	0.000704	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NFATC1—rheumatoid arthritis	3.27e-05	0.000701	CbGpPWpGaD
Valsartan—ALB—Platelet degranulation—TGFB1—rheumatoid arthritis	3.24e-05	0.000695	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	3.18e-05	0.000681	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—IL2RA—rheumatoid arthritis	3.15e-05	0.000674	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CCL5—rheumatoid arthritis	3.13e-05	0.000671	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCR6—rheumatoid arthritis	3.12e-05	0.00067	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—TP53—rheumatoid arthritis	3.11e-05	0.000668	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CCR5—rheumatoid arthritis	3.1e-05	0.000666	CbGpPWpGaD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—rheumatoid arthritis	3.09e-05	0.000662	CbGpPWpGaD
Valsartan—ALB—Hemostasis—ITGAM—rheumatoid arthritis	3.09e-05	0.000662	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CSF2—rheumatoid arthritis	3.08e-05	0.000661	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	3.06e-05	0.000656	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.05e-05	0.000654	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NCF2—rheumatoid arthritis	3.04e-05	0.000652	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—C3—rheumatoid arthritis	3.03e-05	0.00065	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MED1—rheumatoid arthritis	3.02e-05	0.000648	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	2.99e-05	0.000641	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SH2B3—rheumatoid arthritis	2.96e-05	0.000635	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TRAF6—rheumatoid arthritis	2.96e-05	0.000635	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—FADS2—rheumatoid arthritis	2.94e-05	0.000631	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GZMB—rheumatoid arthritis	2.94e-05	0.000631	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SH2B3—rheumatoid arthritis	2.93e-05	0.000627	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCL2—rheumatoid arthritis	2.86e-05	0.000613	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCL3—rheumatoid arthritis	2.86e-05	0.000613	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL6—rheumatoid arthritis	2.85e-05	0.000611	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ENO1—rheumatoid arthritis	2.83e-05	0.000606	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CCR5—rheumatoid arthritis	2.82e-05	0.000604	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	2.82e-05	0.000604	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—B3GNT2—rheumatoid arthritis	2.81e-05	0.000603	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ACP5—rheumatoid arthritis	2.81e-05	0.000603	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—TNF—rheumatoid arthritis	2.81e-05	0.000602	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SAA1—rheumatoid arthritis	2.79e-05	0.000599	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.78e-05	0.000596	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL2RA—rheumatoid arthritis	2.78e-05	0.000596	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—C3—rheumatoid arthritis	2.75e-05	0.000591	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—FN1—rheumatoid arthritis	2.74e-05	0.000587	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NCF1—rheumatoid arthritis	2.74e-05	0.000587	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.64e-05	0.000567	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CD28—rheumatoid arthritis	2.63e-05	0.000564	CbGpPWpGaD
Valsartan—ALB—Hemostasis—GATA3—rheumatoid arthritis	2.62e-05	0.000563	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—BGN—rheumatoid arthritis	2.53e-05	0.000543	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—POMC—rheumatoid arthritis	2.5e-05	0.000535	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TIMP1—rheumatoid arthritis	2.49e-05	0.000533	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—UBE2D1—rheumatoid arthritis	2.48e-05	0.000531	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	2.45e-05	0.000525	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.43e-05	0.000521	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—BDKRB2—rheumatoid arthritis	2.43e-05	0.000521	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCL12—rheumatoid arthritis	2.43e-05	0.000521	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—POMC—rheumatoid arthritis	2.43e-05	0.00052	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6ST—rheumatoid arthritis	2.41e-05	0.000516	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ADRBK1—rheumatoid arthritis	2.4e-05	0.000515	CbGpPWpGaD
Valsartan—ALB—Metabolism—PLD4—rheumatoid arthritis	2.4e-05	0.000514	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALOX5—rheumatoid arthritis	2.33e-05	0.000499	CbGpPWpGaD
Valsartan—ALB—Metabolism—ACAN—rheumatoid arthritis	2.32e-05	0.000497	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—RASGRP1—rheumatoid arthritis	2.27e-05	0.000486	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL6—rheumatoid arthritis	2.26e-05	0.000485	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SYK—rheumatoid arthritis	2.26e-05	0.000484	CbGpPWpGaD
Valsartan—ALB—Hemostasis—RASGRP1—rheumatoid arthritis	2.24e-05	0.00048	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SYK—rheumatoid arthritis	2.23e-05	0.000478	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PRKCQ—rheumatoid arthritis	2.22e-05	0.000475	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—POMC—rheumatoid arthritis	2.2e-05	0.000472	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PRKCQ—rheumatoid arthritis	2.19e-05	0.00047	CbGpPWpGaD
Valsartan—ALB—Metabolism—SLC25A12—rheumatoid arthritis	2.18e-05	0.000467	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—STAT1—rheumatoid arthritis	2.18e-05	0.000467	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CCL2—rheumatoid arthritis	2.16e-05	0.000462	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6R—rheumatoid arthritis	2.15e-05	0.000461	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCL10—rheumatoid arthritis	2.15e-05	0.00046	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTGES—rheumatoid arthritis	2.12e-05	0.000454	CbGpPWpGaD
Valsartan—ALB—Metabolism—GC—rheumatoid arthritis	2.12e-05	0.000454	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.05e-05	0.000439	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CAT—rheumatoid arthritis	2.03e-05	0.000436	CbGpPWpGaD
Valsartan—ALB—Metabolism—PLB1—rheumatoid arthritis	1.97e-05	0.000422	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	1.96e-05	0.000421	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MMP3—rheumatoid arthritis	1.96e-05	0.00042	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—TYK2—rheumatoid arthritis	1.96e-05	0.00042	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ENO1—rheumatoid arthritis	1.9e-05	0.000407	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	1.9e-05	0.000407	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PTK2—rheumatoid arthritis	1.89e-05	0.000404	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.88e-05	0.000402	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.87e-05	0.0004	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PTK2—rheumatoid arthritis	1.86e-05	0.000399	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCL5—rheumatoid arthritis	1.85e-05	0.000396	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—IL2—rheumatoid arthritis	1.84e-05	0.000395	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CSF2—rheumatoid arthritis	1.82e-05	0.00039	CbGpPWpGaD
Valsartan—ALB—Hemostasis—CSF2—rheumatoid arthritis	1.8e-05	0.000386	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—IL2—rheumatoid arthritis	1.79e-05	0.000385	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	1.78e-05	0.000382	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	1.78e-05	0.000381	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	1.73e-05	0.000372	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GC—rheumatoid arthritis	1.73e-05	0.000372	CbGpPWpGaD
Valsartan—ALB—Metabolism—MED1—rheumatoid arthritis	1.73e-05	0.00037	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SPP1—rheumatoid arthritis	1.71e-05	0.000367	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.7e-05	0.000365	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MTHFR—rheumatoid arthritis	1.7e-05	0.000364	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCR5—rheumatoid arthritis	1.67e-05	0.000357	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL2RA—rheumatoid arthritis	1.64e-05	0.000352	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.63e-05	0.00035	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL2—rheumatoid arthritis	1.63e-05	0.000349	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—C3—rheumatoid arthritis	1.63e-05	0.000349	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IL2RA—rheumatoid arthritis	1.62e-05	0.000348	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	1.61e-05	0.000346	CbGpPWpGaD
Valsartan—ALB—Metabolism—ACP5—rheumatoid arthritis	1.61e-05	0.000344	CbGpPWpGaD
Valsartan—ALB—Metabolism—B3GNT2—rheumatoid arthritis	1.61e-05	0.000344	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—VEGFA—rheumatoid arthritis	1.57e-05	0.000336	CbGpPWpGaD
Valsartan—ALB—Hemostasis—MMP1—rheumatoid arthritis	1.55e-05	0.000332	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—LEP—rheumatoid arthritis	1.51e-05	0.000325	CbGpPWpGaD
Valsartan—ALB—Metabolism—BGN—rheumatoid arthritis	1.45e-05	0.00031	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	1.44e-05	0.000308	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—FN1—rheumatoid arthritis	1.43e-05	0.000306	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6ST—rheumatoid arthritis	1.42e-05	0.000305	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MED1—rheumatoid arthritis	1.41e-05	0.000303	CbGpPWpGaD
Valsartan—ALB—Hemostasis—FN1—rheumatoid arthritis	1.41e-05	0.000303	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS2—rheumatoid arthritis	1.39e-05	0.000299	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CD80—rheumatoid arthritis	1.37e-05	0.000294	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CAT—rheumatoid arthritis	1.37e-05	0.000293	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—POMC—rheumatoid arthritis	1.36e-05	0.000291	CbGpPWpGaD
Valsartan—ALB—Metabolism—ALOX5—rheumatoid arthritis	1.33e-05	0.000285	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	1.31e-05	0.000282	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	1.31e-05	0.000282	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—POMC—rheumatoid arthritis	1.3e-05	0.000279	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCL2—rheumatoid arthritis	1.27e-05	0.000273	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6R—rheumatoid arthritis	1.27e-05	0.000272	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ALB—rheumatoid arthritis	1.24e-05	0.000265	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—NOS3—rheumatoid arthritis	1.18e-05	0.000254	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—BGN—rheumatoid arthritis	1.18e-05	0.000254	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.17e-05	0.000251	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TYK2—rheumatoid arthritis	1.16e-05	0.000248	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MTHFR—rheumatoid arthritis	1.14e-05	0.000245	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NOS3—rheumatoid arthritis	1.13e-05	0.000243	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS3—rheumatoid arthritis	1.12e-05	0.00024	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	1.09e-05	0.000234	CbGpPWpGaD
Valsartan—ALB—Metabolism—ENO1—rheumatoid arthritis	1.09e-05	0.000233	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PTGS2—rheumatoid arthritis	1.08e-05	0.000232	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.01e-05	0.000216	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL2—rheumatoid arthritis	9.62e-06	0.000206	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	9.58e-06	0.000205	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6—rheumatoid arthritis	9.57e-06	0.000205	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IL2—rheumatoid arthritis	9.51e-06	0.000204	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	9.34e-06	0.0002	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—POMC—rheumatoid arthritis	9.12e-06	0.000196	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MMP9—rheumatoid arthritis	9.11e-06	0.000195	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NFKB1—rheumatoid arthritis	9.01e-06	0.000193	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	8.88e-06	0.00019	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MAPK8—rheumatoid arthritis	8.86e-06	0.00019	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	8.74e-06	0.000187	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALB—rheumatoid arthritis	8.32e-06	0.000178	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—VEGFA—rheumatoid arthritis	8.18e-06	0.000175	CbGpPWpGaD
Valsartan—ALB—Hemostasis—VEGFA—rheumatoid arthritis	8.08e-06	0.000173	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—NOS3—rheumatoid arthritis	7.96e-06	0.000171	CbGpPWpGaD
Valsartan—ALB—Metabolism—CAT—rheumatoid arthritis	7.81e-06	0.000167	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	7.64e-06	0.000164	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TGFB1—rheumatoid arthritis	7.5e-06	0.000161	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TGFB1—rheumatoid arthritis	7.41e-06	0.000159	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTGS2—rheumatoid arthritis	7.28e-06	0.000156	CbGpPWpGaD
Valsartan—ALB—Metabolism—MTHFR—rheumatoid arthritis	6.52e-06	0.00014	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CAT—rheumatoid arthritis	6.39e-06	0.000137	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TP53—rheumatoid arthritis	6.18e-06	0.000132	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TP53—rheumatoid arthritis	6.1e-06	0.000131	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6—rheumatoid arthritis	5.65e-06	0.000121	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	5.34e-06	0.000114	CbGpPWpGaD
Valsartan—ALB—Metabolism—POMC—rheumatoid arthritis	5.21e-06	0.000112	CbGpPWpGaD
Valsartan—ALB—Metabolism—NOS3—rheumatoid arthritis	4.55e-06	9.75e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—POMC—rheumatoid arthritis	4.27e-06	9.15e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTGS2—rheumatoid arthritis	4.16e-06	8.92e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALB—rheumatoid arthritis	3.89e-06	8.34e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	3.72e-06	7.98e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	3.4e-06	7.3e-05	CbGpPWpGaD
